胃癌中DEC2、HIF-2α的表达及临床意义

doi:10.6040/j.issn.1671-7554.0.2022.1290

摘要/Abstract

摘要： 目的研究分化型胚胎软骨发育基因2(DEC2)和缺氧诱导因子-2α(HIF-2α)在胃癌中的表达以及与临床病理参数之间的关系。方法将胃癌细胞株MKN45和HGC27分为实验组(缺氧72h组)和对照组(常氧72 h组),检测各组细胞DEC2和HIF-2α mRNA及蛋白的表达;并在这两种胃癌细胞株中转染DEC2真核表达质粒,检测DEC2和HIF-2α蛋白水平的表达。另外,通过免疫组织化学染色的方法检测60例胃癌组织及相应的癌旁胃黏膜组织中DEC2和HIF-2α的表达,并分析其相关性。结果缺氧处理后DEC2的mRNA及蛋白表达明显低于对照组,而HIF-2α的表达高于对照组。过表达DEC2后,HIF-2α的表达降低。DEC2在胃癌组织中的表达显著低于癌旁胃黏膜组织(χ2=20.512,P<0.001),HIF-2α的表达则高于癌旁胃黏膜组织(χ2=11.172,P=0.001)。在胃癌组织中DEC2、HIF-2α的表达水平与肿瘤的浸润深度、淋巴结转移及临床分期显著相关。DEC2与HIF-2α的表达在胃癌组织中呈负相关(P<0.001)。结论 DEC2在胃癌细胞及组织中低表达,HIF-2α在胃癌细胞及组织中高表达,两者呈负相关,且与肿瘤发展转移联系密切。

关键词: 胃癌, 分化型胚胎软骨发育基因2, 缺氧诱导因子-2α, 缺氧, 免疫组织化学

Abstract: Objective To investigate the expressions of differentiated embryonic chondrocyte gene 2(DEC2)and hypoxia inducible factor-2α(HIF-2α)and their relationship with the clinicopathological parameters of gastric cancer. Methods The gastric cancer cell lines MKN45 and HGC27 were divided into the experimental groups(hypoxia for 72 hours)and the control group(normoxic for 72 hours). The mRNA and protein expressions of DEC2 and HIF-2α were detected. The overexpression plasmid DEC2 was transfected into the cell lines to detect the protein expressions of DEC2 and HIF-2α. The expressions of DEC2 and HIF-2α in 60 cases of gastric cancer tissues and corresponding adjacent gastric mucosa tissues were detected with immunohistochemical staining, and their correlation was analyzed. Results After hypoxia treatment, the mRNA and protein expressions of DEC2 were significantly decreased in the experimental groups compared with the control groups, while the expressions of HIF-2α were increased. After overexpression of DEC2, the expression of HIF-2α decreased. The expression of DEC2 in gastric cancer tissues was significantly lower than that in adjacent gastric mucosa tissues(χ2=20.512, P<0.001), while the expression of HIF-2α was higher(χ2=11.172, P=0.001). The expressions of DEC2 and HIF-2α were significantly correlated with the depth of tumor invasion, lymph node metastasis and clinical stage, and the expressions of DEC2 and HIF-2α were negatively correlated with each other(P<0.001). Conclusion DEC2 is lowly expressed in gastric cancer cells and tissues, while HIF-2α is highly expressed. They are negatively correlated with other and closely related with the tumor development and metastasis.

Key words: Gastric cancer, Differentiated embryonic chondrocyte gene 2, Hypoxia inducible factor-2α, Hypoxia, Immunohistochemistry

中图分类号:

R735.2

樊荣,李彬彬,马晓丽,汪运山,郏雁飞. 胃癌中DEC2、HIF-2α的表达及临床意义[J]. 山东大学学报 (医学版), 2023, 61(7): 12-18.

FAN Rong, LI Binbin, MA Xiaoli, WANG Yunshan, JIA Yanfei. Expressions and clinical significance of DEC2 and HIF-2α in gastric cancer[J]. Journal of Shandong University (Health Sciences), 2023, 61(7): 12-18.

参考文献

[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2] Thrift AP, El-Serag HB. Burden of gastric cancer [J]. Clin Gastroenterol Hepatol, 2020, 18(3): 534-542.
[3] Roy S, Kumaravel S, Sharma A, et al. Hypoxic tumor microenvironment: implications for cancer therapy [J]. Exp Biol Med(Maywood), 2020, 245(13): 1073-1086.
[4] 牟宏芳, 赵以览, 张晓静, 等. 缺氧及缺氧诱导因子对不同器官相关疾病调控的研究进展 [J]. 兰州大学学报(医学版), 2022, 48(5): 72-78. MOU Hongfang, ZHAO Yilan, ZHANG Xiaojing, et al. Research progress in the regulation of hypoxia and hypoxia-inducible factors in different organ-related diseases [J]. Journal of Lanzhou University(Medical Sciences), 2022, 48(5): 72-78.
[5] 曹悦悦, 吴雪琼, 赵思文, 等. 转录调节因子DEC2和肿瘤的研究进展[J]. 现代肿瘤医学, 2015, 23(7): 1002-1004. CAO Yueyue, WU Xueqiong, ZHAO Siwen, et al. A review of a transcriptional regulation factor DEC2 and tumor [J]. Journal of Modern Oncology, 2015, 23(7): 1002-1004.
[6] Yang X, Wu JS, Li M, et al. Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma [J]. J Exp Clin Cancer Res, 2021, 40(1): 169.
[7] 曹毛毛, 李贺, 孙殿钦, 等. 2000—2019年中国胃癌流行病学趋势分析[J]. 中华消化外科杂志, 2021, 20(1): 102-109. CAO Maomao, LI He, SUN Dianqin, et al. Epidemiological trend analysis of gastric cancer in China from 2000 to 2019 [J]. Chinese Journal Digestive Surgery, 2021, 20(1): 102-109.
[8] Lei ZN, Teng Q X, Tian Q, et al. Signaling pathways and therapeutic interventions in gastric cancer [J]. Signal Transduct Target Ther, 2022, 7(1): 358.
[9] Hirano A, Hsu PK, Zhang L, et al. DEC2 modulates orexin expression and regulates sleep [J]. Proc Natl Acad Sci U S A, 2018, 115(13): 3434-3439.
[10] Sato F, Kohsaka A, Bhawal UK, et al. Potential roles of Dec and Bmal1 genes in interconnecting circadian clock and energy metabolism [J]. Int J Mol Sci, 2018, 19(3):781.
[11] De Martin X, Sodaei R, Santpere G. Mechanisms of binding specificity among bHLH transcription factors [J]. Int J Mol Sci, 2021, 22(17): 9150. doi: 10.3390/ijms22179150.
[12] Zhang D, Zheng Q, Wang C, et al. BHLHE41 suppresses MCF-7 cell invasion via MAPK/JNK pathway [J]. J Cell Mol Med, 2020, 24(7): 4001-4010.
[13] Nagata T, Minami K, Yamamoto M, et al. BHLHE41/DEC2 expression induces autophagic cell death in lung cancer cells and is associated with favorable prognosis for patients with lung adenocarcinoma [J]. Int J Mol Sci, 2021, 22(21): 11509. doi: 10.3390/ijms222111509.
[14] Bigot P, Colli LM, Machiela MJ, et al. Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41 [J]. Nat Commun, 2016, 7: 12098. doi: 10.1038/ncomms12098.
[15] Numata A, Kwok HS, Kawasaki A, et al. The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia [J]. Nat Commun, 2018, 9(1): 1622. doi: 10.1038/s41467-018-03854-0.
[16] Liu Q, Wu Y, Yoshizawa T, et al. Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells [J]. Int J Molr Med, 2016, 38(6): 1727-1733.
[17] Li P, Jia YF, Ma XL, et al. DEC2 suppresses tumor proliferation and metastasis by regulating ERK/NF-κB pathway in gastric cancer [J]. Am J Cancer Res, 2016, 6(8): 1741-1757.
[18] Parks SK, Cormerais Y, Pouysségur J. Hypoxia and cellular metabolism in tumour pathophysiology [J]. J Physiol, 2017, 595(8): 2439-2450.
[19] Liao Y, Lu W, Che Q, et al. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level [J]. PLoS One, 2014, 9(6): e99907. doi: 10.1371/journal.pone.0099907.
[20] Chen S, Dong QJ, Wan ZA, et al. BHLHE41 overexpression alleviates the malignant behavior of colon cancer cells induced by hypoxia via modulating HIF-1α/EMT pathway [J]. Gastroenterol Res Pract, 2022, 2022: 6972331. doi: 10.1155/2022/6972331.
[21] Kusunose N, Akamine T, Kobayashi Y, et al. Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial(Müller)cells [J]. Jap J Ophthalmol, 2018, 62(6): 677-685.
[22] Befani C, Liakos P. The role of hypoxia-inducible factor-2 alpha in angiogenesis [J]. J Cell Physiol, 2018, 233(12): 9087-9098.
[23] Murugesan T, Rajajeyabalachandran G, Kumar S, et al. Targeting HIF-2α as therapy for advanced cancers [J]. Drug Discov Today, 2018, 23(7): 1444-1451.
[24] Wang Y, Li Z, Zhang H, et al. HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer [J]. Cancer Biol Ther, 2010, 10(4): 376-382.
[25] Tong WW, Tong GH, Chen XX, et al. HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma [J]. Int J Oncol, 2015, 46(1): 233-242.
[26] Griffiths EA, Pritchard SA, Mcgrath SM, et al. Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis [J]. Br J Cancer, 2008, 98(5): 965-973.
[27] Wu Y, Sato H, Suzuki T, et al. Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2 [J]. Int J Mol Med, 2015, 35(3): 815-820.

相关文章 15

[1]	黄方康瑞吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-.
[2]	穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41.
[3]	郭崇勇,赵朋,刘海盟,王强, 贾宗师,张建. 胸前丘疹为首发表现的胃癌1例[J]. 山东大学学报 (医学版), 2023, 61(4): 119-120.
[4]	王赞,徐晓涵,张瑜,曲业敏,王明义,陈艾. 幽门螺杆菌感染对胃癌细胞糖酵解的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 16-24.
[5]	付佳,王路路,胡帅,陈哲平,刘东义,李青松,卢国栋,张贺,赵鑫,冯昌. 不同入路腰方肌阻滞对胃癌根治患者术后恢复的影响[J]. 山东大学学报 (医学版), 2022, 60(8): 50-57.
[6]	王景,谢艳,李培龙,杜鲁涛,王传新. GZMB基因cg16212145位点的异常甲基化芯片测定对胃癌早筛的价值[J]. 山东大学学报 (医学版), 2022, 60(6): 26-34.
[7]	包舒晴,杨明月,刘端瑞,汪运山,郏雁飞. NOX4在幽门螺旋杆菌诱导胃癌细胞ROS中的作用[J]. 山东大学学报 (医学版), 2022, 60(6): 19-25.
[8]	高惠茹,杜甜甜,王允山,杜鲁涛,王传新. 基于单细胞转录组测序数据分析胃癌调节性T细胞特征[J]. 山东大学学报 (医学版), 2022, 60(5): 43-49.
[9]	徐歌,李青,张灿灿,田永杰. 子宫腺肌病组织及原代细胞中PARP-1、HIF-1α的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(4): 55-61.
[10]	穆彦熹,汪文杰,陈康,姚亚龙,李金洲,魏浩旗,刘海鹏,黄泽平,陈晓. 探寻一家系短期3例胃癌的临床病理及其相关肿瘤特征[J]. 山东大学学报 (医学版), 2022, 60(11): 96-101.
[11]	褚晏,刘端瑞,朱文帅,樊荣,马晓丽,汪运山,郏雁飞. DNA甲基化转移酶在胃癌中的表达及其临床意义[J]. 山东大学学报 (医学版), 2021, 59(7): 1-9.
[12]	罗兵. EB病毒对胃癌表观遗传学的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 30-39.
[13]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[14]	支梦伟,江志伟,戴新娟,王刚,程伟. 加速康复外科指导下胃癌患者围手术期心率变异度的临床观察[J]. 山东大学学报 (医学版), 2020, 58(11): 85-91.
[15]	王亚杰,闻蓓,施浩宇,商亮,董康迪,李乐平. 胃癌合并轻型血友病术后出血1例[J]. 山东大学学报 (医学版), 2020, 58(1): 91-93.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed